Fresh analysis indicates that patients who stop using new slimming jabs like semaglutide or tirzepatide tend to recover reduced body mass at a significantly accelerated pace than those who stop traditional diet and exercise programs.
Published data in a leading health publication points out that while overweight people can lose substantial amounts of their total mass while undergoing treatment, the weight is regained at an estimated rate of 0.8 kg per month upon discontinuation.
"People using such drugs should be cognizant of the potential of quick weight regain when the medication ends," stated researcher Dr. Susan Jebb.
Such speed of recovery means a return to pre-treatment mass in about a year and a half.
Weighing Therapies
The study, which reviewed dozens of trials involving over 9,000 of participants, contrasted the outcomes of GLP-1 agonists with older methods.
The team point out that individuals who shed pounds through dieting generally see a more gradual creep back—perhaps 100 grams monthly—post-intervention.
Understanding the Rapid Regain
Nutrition scientists believe the way of the drugs explains the accelerated rebound.
These medications copy a natural hormone called glucagon-like peptide-1, which controls hunger.
"Sustained high doses of GLP-1 concentrations several times higher than the body's typical production might result in the system to generate a reduced amount of its own natural hormone, and may also diminish sensitivity to its actions," noted Dr. Adam Collins, a dietetics expert.
"Withdrawal of this medication leads to hunger is no longer kept in check, making overeating much more probable."
A Chronic Issue?
Health authorities recommend the jabs for people with weight-linked health risks, alongside prescribed diet and exercise modifications.
Many experts say that, considering the significant potential of relapse, the therapy might need to be long-term.
This perspective is echoed by pharmaceutical companies, who state that the results "emphasize the chronic character of obesity," akin to managing conditions like diabetes.
Patient Testimonies
Individuals who have come off the jabs describe a intense resurgence of appetite.
"It was like a trigger that goes on and you become extremely hungry," recalled a patient.
The struggle is worsened if individuals have not developed lasting dietary or behavioural modifications during treatment.
Widespread Interest
Figures indicate that a significant number of adults in the UK have tried these injections in the past year, with demand continuing to grow.
- Adoption is greater among women than men.
- The 40s and 50s demographic shows the greatest usage rates.
- A large proportion obtain the medications through private healthcare rather than public health services.
Ultimately, clinicians emphasize that while the jabs are effective agents for shedding pounds, they are not a permanent solution and maintained weight loss hinges on integrated lifestyle management.
